International Stem Cell Stock Current Valuation
| ISCO Stock | USD 0.10 0.01 9.09% |
Valuation analysis of International Stem Cell helps investors to measure International Stem's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that International Stem's price fluctuation is out of control at this time. Calculation of the real value of International Stem Cell is based on 3 months time horizon. Increasing International Stem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the International otc stock is determined by what a typical buyer is willing to pay for full or partial control of International Stem Cell. Since International Stem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of International OTC Stock. However, International Stem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.1 | Real 0.082 | Hype 0.1 |
The intrinsic value of International Stem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence International Stem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of International Stem Cell helps investors to forecast how International otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of International Stem more accurately as focusing exclusively on International Stem's fundamentals will not take into account other important factors: International Stem Cell OTC Stock Current Valuation Analysis
International Stem's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current International Stem Current Valuation | 5.11 M |
Most of International Stem's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, International Stem Cell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, International Stem Cell has a Current Valuation of 5.11 M. This is 99.96% lower than that of the Biotechnology sector and 99.89% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
International Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses International Stem's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of International Stem could also be used in its relative valuation, which is a method of valuing International Stem by comparing valuation metrics of similar companies.International Stem is currently under evaluation in current valuation category among its peers.
International Fundamentals
| Return On Equity | -6.92 | |||
| Return On Asset | -0.0685 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 5.11 M | |||
| Shares Outstanding | 8 M | |||
| Shares Owned By Insiders | 53.77 % | |||
| Price To Earning | 103.12 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 7.18 M | |||
| Gross Profit | 4.24 M | |||
| EBITDA | (509 K) | |||
| Net Income | (899 K) | |||
| Cash And Equivalents | 586 K | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 4.31 M | |||
| Current Ratio | 0.64 X | |||
| Book Value Per Share | (0.58) X | |||
| Cash Flow From Operations | (1.3 M) | |||
| Earnings Per Share | (0.04) X | |||
| Target Price | 0.54 | |||
| Number Of Employees | 26 | |||
| Beta | 0.65 | |||
| Market Capitalization | 1.68 M | |||
| Total Asset | 4.95 M | |||
| Retained Earnings | (114.79 M) | |||
| Working Capital | (2.55 M) | |||
| Current Asset | 2.99 M | |||
| Current Liabilities | 5.54 M | |||
| Z Score | -31.2 | |||
| Net Asset | 4.95 M |
About International Stem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze International Stem Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of International Stem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of International Stem Cell based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with International Stem
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if International Stem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Stem will appreciate offsetting losses from the drop in the long position's value.Moving against International OTC Stock
| 0.46 | BKRKY | Bank Rakyat Normal Trading | PairCorr |
| 0.44 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.41 | PPERY | Bank Mandiri Persero Normal Trading | PairCorr |
| 0.41 | PBCRY | Bank Central Asia | PairCorr |
| 0.41 | MEDS | Trxade Group Symbol Change | PairCorr |
The ability to find closely correlated positions to International Stem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace International Stem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back International Stem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling International Stem Cell to buy it.
The correlation of International Stem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as International Stem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if International Stem Cell moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for International Stem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in International OTC Stock
International Stem financial ratios help investors to determine whether International OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Stem security.